Stockreport

FibroBiologics CEO Issues Letter to Shareholders

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and [Read more]